Navigation Links
Micromet Added to Russell 3000 Index
Date:6/29/2009

Nycomed. Micromet's licensee Morphotek, a wholly-owned subsidiary of Eisai, is also expected to initiate a first phase 1 clinical trial with Micromet's glycolipid-binding human antibody MT228 for the treatment of melanoma.

Micromet's preclinical product pipeline includes several novel BiTE antibodies generated with its proprietary BiTE antibody platform technology. A BiTE antibody targeting CEA for the treatment of solid tumors is being developed in collaboration with MedImmune. In addition, Micromet has entered into an option, collaboration and license agreement with Bayer Schering Pharma AG under which Bayer Schering Pharma was granted an exclusive option to license a specified BiTE antibody against an undisclosed solid tumor target. Other BiTE antibodies targeting MSCP, CD33, HER2, EGFR and other targets are in various stages of preclinical development.

Forward-Looking Statements

This release contains certain forward-looking statements that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. These forward-looking statements include statements regarding the efficacy, safety and intended utilization of our product candidates, the conduct, timing and results of future clinical trials, and expectations of the future expansion of our product pipeline and collaborations. You are urged to consider statements that include the words "ongoing," "may," "will," "believes," "potential," "expects," "plans," "anticipates," "intends," or the negative of those words or other similar words to be uncertain and forward-looking. Factors that may cause actual results to differ materially from any future results expressed or implied by any forward-looking statements include the risk that product candidates that appeared promising in early research, preclinical studies or clinical trials do n
'/>"/>

SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Micromet to Host Conference Call and Webcast to Discuss Blinatumomab Data Presented at EHA on June 8, 2009
2. Micromet Presents Update at ASCO 2009 on a Phase 1b Combination Study of Adecatumumab and Docetaxel
3. Micromet to Present New Clinical Data on Blinatumomab at EHA and on Adecatumumab at ASCO
4. Micromet, Inc. to Host Conference Call and Webcast to Report First Quarter 2009 Financial Results on May 6, 2009
5. Micromet Presents Data at AACR Meeting Showing Elimination of Colorectal Cancer Stem Cells by BiTE Antibody MT110
6. Micromet to Present at the Future Leaders in the Biotech Industry Conference on April 2, 2009
7. Micromet Adds Sir Walter Bodmer and Bernard Fox to Its Advisory Panel for BiTE Antibody Therapeutics
8. Micromet to Present Six Posters on Progress of BiTE Antibodies at the Annual Meeting of American Association for Cancer Research
9. Micromet, Inc. To Regain Rights to Blinatumomab in North America; Reports Financial Results for the Fourth Quarter and Full Year ended December 31, 2008
10. Micromet to Present at the Cowen Health Care Conference on March 17, 2009
11. Micromet Adds Former Head of Roche Oncology Kapil Dhingra, MD to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... CA (PRWEB) May 21, 2013 ... at the University of California, San Diego for a ... load bearing Gravitic™ MRI (Magnetic Resonance Imaging) with that ... renowned for its continued pursuit of improved healthcare by ... Spinal MRI is an extremely valuable tool for evaluating ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 PathoGenetix, Inc., ... bacterial strain typing, announced today that it has successfully ... E. coli strains obtained from the Centers for Disease ... Scanning™ (GSS™) technology. The findings are detailed in a ... the American Society for Microbiology in Denver on Monday. ...
(Date:5/20/2013)... , Collaboration with the ... in treatment of mastitis , ... to begin in the second half 2013 ... Phosphagenics Limited (ASX: POH, OTCQX: PPGNY) will collaborate ... Service (ARS) to develop and trial products targeting the ...
(Date:5/20/2013)... , May 20, 2013  MiMedx Group, Inc. ... and marketer of patent protected regenerative biomaterials and bioimplants ... has secured a revolving line of credit with Bank ... is secured by the Company,s accounts receivable and inventory, ... May 1, 2014.  The facility will be used for ...
Breaking Biology Technology:Vital Imaging Makes Greater Commitment into MRI Research 2Vital Imaging Makes Greater Commitment into MRI Research 3New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 2New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 3Phosphagenics Signs Research Agreement with the Agricultural Research Service 2
... cells have been touted as a cleaner solution to ... cars to computers. But one reason fuel ... endurance. Over time, the catalysts used even in today,s ... that converts fuel into electricity. In addition, current technology ...
... YORK, March 31, 2011 Reportlinker.com announces ... available in its catalogue: ... http://www.reportlinker.com/p096374/Molecular-Diagnostics-Markets.html The technologies that ... fluorescent in situ hybridization (FISH), second-generation biochips ...
... MOUNTAIN VIEW, Calif., March 31, 2011 Clontech Laboratories, Inc., ... launch of its SMARTer Ultra Low RNA Kit for ... Inc. This kit uses a modified version of Clontech,s patented ... to facilitate transcriptome analysis from as little as 100 pg ...
Cached Biology Technology:Novel nanowires boost fuel cell efficiency 2Reportlinker Adds Molecular Diagnostics Markets 2Reportlinker Adds Molecular Diagnostics Markets 3Reportlinker Adds Molecular Diagnostics Markets 4Reportlinker Adds Molecular Diagnostics Markets 5Reportlinker Adds Molecular Diagnostics Markets 6Reportlinker Adds Molecular Diagnostics Markets 7Reportlinker Adds Molecular Diagnostics Markets 8Reportlinker Adds Molecular Diagnostics Markets 9Reportlinker Adds Molecular Diagnostics Markets 10Reportlinker Adds Molecular Diagnostics Markets 11Reportlinker Adds Molecular Diagnostics Markets 12Reportlinker Adds Molecular Diagnostics Markets 13Reportlinker Adds Molecular Diagnostics Markets 14Reportlinker Adds Molecular Diagnostics Markets 15Reportlinker Adds Molecular Diagnostics Markets 16Reportlinker Adds Molecular Diagnostics Markets 17Reportlinker Adds Molecular Diagnostics Markets 18Clontech Laboratories, Inc. Releases the SMARTer™ Ultra Low RNA Kit for Illumina® Sequencing 2Clontech Laboratories, Inc. Releases the SMARTer™ Ultra Low RNA Kit for Illumina® Sequencing 3
(Date:5/21/2013)... When infections occur in the body, stem cells ... multiplying and differentiating into mature immune cells that ... inflammation can deplete these cell populations, potentially leading ... as cancer. Now, a team of researchers led ... (Caltech) has found that, in mouse models, the ...
(Date:5/21/2013)... most deadly when they metastasize and spread tumors throughout ... becomes very difficult for doctors to locate and treat ... the University of Missouri have found a way to ... they may be in the body. Michael Lewis, an ... Veterinary Medicine, says being able to target secondary tumors ...
(Date:5/21/2013)... Illinois at Chicago College of Medicine will study gender differences ... main energy source -- and how changes in fat metabolism ... million, 4-year grant from the National Heart, Lung and Blood ... fuel for energy. These changes may play a major role ... men and women, says E. Douglas Lewandowski, director of the ...
Breaking Biology News(10 mins):Keeping stem cells strong 2MU researchers develop radioactive nanoparticles that target cancer cells 2Do men's and women's hearts burn fuel differently? 2
... ship hulls with artificial shark skin could help ships ... barnacles on ship hulls is a major cause of ... offers a structural design that prevents this so called ... Sciences, Bremen, Germany, is presenting his work on the ...
... a cliff. Another prefers to read a book and ... is a mystery, but for the first time researchers ... , Scientists at Fred Hutchinson Cancer Research Center ... is related to the development of an almond-shaped area ...
... hulls with artificial shark skin could help ships sailing ... on ship hulls is a major cause of increased ... a structural design that prevents this so called 'bio-fouling'. ... Bremen, Germany, is presenting his work on the application ...
Cached Biology News:Study identifies gene in mice that may control risk-taking behavior in humans 2Study identifies gene in mice that may control risk-taking behavior in humans 3
Animal Origin Free...
IHC Detection Kit (Broad Spectrum AEC)....
...
... Antibody Modification Services ,,GenScript ... antibody labeling and antibody fragmentation. Labeling ... signals for visualization and quantitation of ... it is preferable to use only ...
Biology Products: